These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 21982711)
1. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Wan M; Leavens KF; Saleh D; Easton RM; Guertin DA; Peterson TR; Kaestner KH; Sabatini DM; Birnbaum MJ Cell Metab; 2011 Oct; 14(4):516-27. PubMed ID: 21982711 [TBL] [Abstract][Full Text] [Related]
2. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878 [TBL] [Abstract][Full Text] [Related]
3. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Yecies JL; Zhang HH; Menon S; Liu S; Yecies D; Lipovsky AI; Gorgun C; Kwiatkowski DJ; Hotamisligil GS; Lee CH; Manning BD Cell Metab; 2011 Jul; 14(1):21-32. PubMed ID: 21723501 [TBL] [Abstract][Full Text] [Related]
4. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. Yuan M; Pino E; Wu L; Kacergis M; Soukas AA J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877 [TBL] [Abstract][Full Text] [Related]
5. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D Nat Med; 2013 Aug; 19(8):1054-60. PubMed ID: 23832089 [TBL] [Abstract][Full Text] [Related]
7. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. Bose SK; Kim H; Meyer K; Wolins N; Davidson NO; Ray R J Virol; 2014 Apr; 88(8):4195-203. PubMed ID: 24478438 [TBL] [Abstract][Full Text] [Related]
8. Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway. Tan SH; Shui G; Zhou J; Shi Y; Huang J; Xia D; Wenk MR; Shen HM Autophagy; 2014 Feb; 10(2):226-42. PubMed ID: 24296537 [TBL] [Abstract][Full Text] [Related]
9. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Lu M; Wan M; Leavens KF; Chu Q; Monks BR; Fernandez S; Ahima RS; Ueki K; Kahn CR; Birnbaum MJ Nat Med; 2012 Feb; 18(3):388-95. PubMed ID: 22344295 [TBL] [Abstract][Full Text] [Related]
10. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773 [TBL] [Abstract][Full Text] [Related]
12. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559 [TBL] [Abstract][Full Text] [Related]
13. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637 [TBL] [Abstract][Full Text] [Related]
14. Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. Saoncella S; Tassone B; Deklic E; Avolio F; Jon C; Tornillo G; De Luca E; Di Iorio E; Piva R; Cabodi S; Turco E; Pandolfi PP; Calautti E Stem Cells; 2014 Mar; 32(3):754-69. PubMed ID: 24123662 [TBL] [Abstract][Full Text] [Related]
15. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation. Sajan MP; Ivey RA; Lee MC; Farese RV J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359 [TBL] [Abstract][Full Text] [Related]
16. Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling. Zhao H; Zhang F; Sun D; Wang X; Zhang X; Zhang J; Yan F; Huang C; Xie H; Lin C; Liu Y; Fan M; Yan W; Chen Y; Lian K; Li Y; Zhang L; Wang S; Tao L Diabetes; 2020 Jun; 69(6):1164-1177. PubMed ID: 32184272 [TBL] [Abstract][Full Text] [Related]
17. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Leavens KF; Easton RM; Shulman GI; Previs SF; Birnbaum MJ Cell Metab; 2009 Nov; 10(5):405-18. PubMed ID: 19883618 [TBL] [Abstract][Full Text] [Related]
18. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307 [TBL] [Abstract][Full Text] [Related]
19. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice. Tripathy S; Jump DB J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444 [TBL] [Abstract][Full Text] [Related]
20. Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity. Sajan MP; Acevedo-Duncan ME; Standaert ML; Ivey RA; Lee M; Farese RV Diabetes; 2014 Aug; 63(8):2690-701. PubMed ID: 24705403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]